SynthesisThe American journal of tropical medicine and hygiene2025
Prevalence Estimates and Distribution of Entamoeba histolytica and Entamoeba dispar Infections in Several Regions of Thailand: A Systematic Review and Meta-Analysis.
Synthesis in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of intestinal immune responses to Entamoeba dispar using the first domestic clinical isolate in Japan.PLoS neglected tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Entamoeba histolytica (E. histolytica) causes amebiasis, which is a major health concern in tropical regions, including Thailand. This systematic review and meta-analysis aimed to assess the prevalence, distribution, and epidemiological trends of E. histolytica and morphologically identical species infections in Thailand to inform public health strategies. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, this study was registered in PROSPERO (CRD42025636219). A comprehensive search in the PubMed, EMBASE, Journal@Ovid, Nursing & Allied Health Premium, Scopus, and the Thai Journal Citation Index databases was conducted. Two authors independently screened the studies, extracted data, and assessed quality using the Joanna Briggs Institute critical appraisal tool. The meta-analysis was conducted by using logit transformation and random effects models, with heterogeneity assessed via Q tests, I2 statistics, and meta-regression. Publication bias was examined by using funnel plots and Egger's test. Of 899 records, 44 studies with 36,720 participants met the inclusion criteria. The overall prevalence of E. histolytica and infections with morphologically identical species in Thailand was 1.30% (95% CI: 0.89-1.89%) with high heterogeneity (I2 = 92.0%). The highest prevalence was in western (2.86%) and northeastern Thailand (1.93%). High-risk groups, including dam personnel (10.28%), individuals with intellectual disabilities (7.05%), and orphaned children (3.95%), exhibited elevated prevalence levels. Molecular methods resulted in the detection of higher rates (5.12%) than traditional techniques. Despite low overall prevalence, regional variations and high-risk populations highlight the need for sensitive diagnostics, targeted interventions, and continuous surveillance to reduce the burden of amebiasis in Thailand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.